By Business/Source
Currency:USD
2022/FY
Stock NameRevenueRatio
Developing treatments through gene therapy and other means for patients with neuromuscular and8.09M100.00%
By Country/Region
Currency:USD
2022/FY
Stock NameRevenueRatio
United States8.09M100.00%